Epidemiology estimates of hepatitis D in individuals co‐infected with human immunodeficiency virus and hepatitis B virus, 2002–2018: A systematic review and meta‐analysis. Issue 7 (18th May 2021)

• Record Type: Journal Article
• Authors: Shen, Dan‐Ting; Han, Pei‐Chun; Ji, Dong‐Ze; Chen, Hai‐Yan; Cao, Wei‐Dong; Goyal, Hemant; Xu, Hua‐Guo
• Is Part Of: Journal of viral hepatitis. Volume 28:Issue 7(2021)
• Page Start: 1057
• Page End: 1067
• Publication Date: 2021-05-18
• Subjects: HCC -- HDV -- HIV -- IVDU -- Prevalence; Hepatitis, Viral -- Periodicals; Hepatitis, Viral, Animal; Hepatitis, Viral, Human; 616.3623
• DOI: 10.1111/jvh.13512
• Languages: English
• ISSNs: 1352-0504

Abstract

Abstract: Hepatitis delta virus (HDV) is an obligate satellite of hepatitis B virus (HBV). HIV/HDV co‐infection is associated with a high rate of hepatic decompensation events and death. We aimed to characterize the epidemiology of HDV infection in HIV/HBV co‐infected individuals. We systematically searched PubMed, Embase, Cochrane Library, Web of Science, CINAHL and Scopus for studies published from 1 Jan 2002 to 7 May 2018 measuring prevalence of HDV among the HIV population. Pooled seroprevalence was calculated with the DerSimonian–Laird random‐effects model. Our search returned 4624 records, 38 of which met the inclusion and exclusion criteria. These studies included data for 63 cohorts from 18 countries and regions. The overall HDV seroprevalence of HIV‐infected individuals was 1.03% (95% CI 0.43–1.85) in 2002–2018 globally. Moreover, the estimated pooled HDV seroprevalence among the general population was 1.07% (95% CI 0.65–1.59) in 2002–2018, which was not significantly different from the HDV seroprevalence of individuals living with HIV ( p = 0.951). The overall HDV seroprevalence of the HBsAg positive population was 12.15% (95% CI 10.22–14.20), p = 0.434 when compared with the corresponding data of HIV/HBV co‐infected individuals. This meta‐analysis suggested that there was no difference between the HDV seroprevalence in HIV‐infected individuals and the general population.